Clinical Efficacy and Safety of Laparoscopic Sleeve Gastrectomy in Obese Patients With PCOS
NCT ID: NCT05536583
Last Updated: 2022-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2013-05-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-omics Analysis of Women With PCOS and Obesity Compared With Non-PCOS Obese Controls
NCT05468476
Analysis of Clinical Characteristics and Study of Diagnostic Markers in Patients with Polycystic Ovary Syndrome
NCT05063383
The Secretion of Incretin Hormones in Patients With Polycystic Ovary Syndrome
NCT02126592
Effect of Visceral Manipulation on PCOS
NCT05029492
Surgical and Non Surgical Treatment Option in Poly Cystic Ovary Cases
NCT05699356
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All PCOS patients with obesity underwent LSG. A multidisciplinary team evaluated participants with obesity at baseline, 1, 3, 6, 12, 24, and 36 months after LSG. Anthropometrics, Metabolic indicators, sex hormones, menstruation，glucose-lipid metabolic markers, and hepatic steatosis were measured baseline and postoperative.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PCOS group
Obese Patients with PCOS underwent LSG
Laparoscopic sleeve Gastrectomy
Laparoscopic sleeve Gastrectomy
Control group
Sample obese patients without PCOS underwent LSG
Laparoscopic sleeve Gastrectomy
Laparoscopic sleeve Gastrectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laparoscopic sleeve Gastrectomy
Laparoscopic sleeve Gastrectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI over 37.5 kg/m2, or BMI over 32.5 kg/m2 with diabetes which meets the recommended cutoff for bariatric surgery of the Guidelines for surgical treatment of obesity accompanied with or without type 2 diabetes in China.
Exclusion Criteria
* secondary obesity caused by endocrine disorders;
* history of more than one bariatric procedure;
* severe hepatic, renal or heart dysfunction;
* mental illnesses or intellectual disability.
* pregnancy or lactation
* contraindications for laparoscopic surgery, such as gastrointestinal diseases of intra-abdominal infection, adhesions, etc.,
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai 10th People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhang Manna
Director
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LSG in PCOS patients
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.